Subcutaneous immunoglobulin: Clinical Trials

3 trials of Subcutaneous immunoglobulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 31Recruiting 1

Follow Subcutaneous immunoglobulin: new trials by email Literature Review of Subcutaneous immunoglobulin trials Research Report on Subcutaneous immunoglobulin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Intravenous immunoglobulin, Trimethoprim / Sulfamethoxazole, Amoxicillin clavulanic acid - Myeloma, Non-Hodgkin's Lymphoma
Phase 2 / Phase 3RecruitingMonash University9002025-05-062025-10-07
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Subcutaneous immunoglobulin - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Phase 2CompletedUniversity of Aarhus302010-04-012011-11-10
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Subcutaneous immunoglobulin, Intravenous immunoglobulin - Multifocal Motor Neuropathy
Phase 2CompletedUniversity of Aarhus102005-08-012008-02-21

Conditions studied

Infections (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Neoplasms, Plasma Cell (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Sponsors

University of Aarhus (2)  ·  Monash University (1)

Countries

Denmark (2)  ·  Australia (1)

Top investigators

Henning Andersen, MD, DMSc (1)  ·  Johannes Jakobsen, Dr., MD (1)  ·  Johannes Jakobsen, Professor (1)  ·  Zoe McQuilten, Professor (1)

Results publications

PMID 19236457, PMID 42578463